Nurse Practitioner Program year 2022 Reported 2021–2022 Source: CMS Open Payments, 2026 publication

Sarah Bruney

Nurse Practitioner Saint Johns, MI Nurse Practitioner

NPI 1710281563 CMS profile 10921506

1501 Waterford Pkwy Ste B, Saint Johns, MI 48879

Open in the dashboard

General payments

$61,951

155 records reported · program years 2021–2022

Research payments

$0

Paid to them · None reported · program years 2021–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Sarah Bruney of Saint Johns, MI is reported in the CMS Open Payments database as having received $61,951 across 155 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $13,991 31
2021 General $47,960 124

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Bruney
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Sarah Bruney were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Sarah Bruney Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $47,960 $135 $40–$426 $132
2022 $13,991 $152 $48–$470 $149
2023 $0 $166 $54–$529 $160
2024 $0 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2022
  1. AbbVie, Inc. $38,949 72 payments
  2. Lilly USA, LLC $6,681 15 payments
  3. Biohaven Pharmaceuticals, Inc. $6,296 27 payments
  4. Teva Pharmaceuticals USA, Inc. $5,674 23 payments
  5. Allergan Inc. $2,608 4 payments
  6. Biohaven Pharmaceutical Holding Company Ltd. $1,637 9 payments
  7. Masimo Corporation $54 1 payment
  8. Lundbeck LLC $29 2 payments
  9. Amgen Inc. $13 1 payment
  10. GRT US Holding, Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $59,260 46 payments
  2. Food and Beverage $1,497 89 payments
  3. Travel and Lodging $1,052 17 payments
  4. Consulting Fee $100 1 payment
  5. Education $43 2 payments
Products named General payments · program years 2021–2022
  1. UBRELVY $41,389 69 payments
  2. NURTEC ODT $7,933 36 payments
  3. EMGALITY $6,680 14 payments
  4. AJOVY $5,674 23 payments
  5. Patient SafetyNet Console $54 1 payment
  6. BOTOX $38 2 payments
  7. QULIPTA $29 4 payments
  8. VYEPTI $29 2 payments
  9. REYVOW $13 1 payment
  10. AIMOVIG $13 1 payment
  11. Other $11 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

155 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record